EUVIMEDEUVIMED entdecken
Crossref

Disease‐Specific Metabolic Patterns in Progressive Supranuclear Palsy with Richardson's Syndrome and Variants: A Longitudinal Study

Fangyang Jiao iD, Huamei Lin, Jiaying Lu iD, Fengtao Liu iD, Jing Wang, Jianjun Wu, Hua Pang, Jian Wang iD, Chuantao Zuo iD, Ping Wu, Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI)

Movement Disorders · 2026

DOI: 10.1002/mds.70369 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2026. Verfasst von Fangyang Jiao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive, Parkinsonian Disorders. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, STI2030-Major Project of China, International Human Phenome Project: Deep Phenomics Study of Sleep Disorders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Progressive supranuclear palsy (PSP) is a rare tauopathy with multiple clinical phenotypes. The PSP‐related metabolic pattern (PSPRP) has proved useful for differentiating PSP from other parkinsonian syndromes, but type‐specific metabolic patterns remain incompletely characterized.

Objective

This study aimed to identify type‐specific metabolic patterns in PSP and evaluate their ability to monitor progression and predict conversion of variant PSP (vPSP) to PSP with Richardson's syndrome (PSP‐RS).

Methods

PSP‐RS, PSP with predominant parkinsonism (PSP‐P), PSP with predominant gait freezing (PSP‐PGF), and PSP with predominant postural instability (PSP‐PI) underwent baseline and follow‐up positron emission tomography with 18 F‐fluorodeoxyglucose ( 18 F‐FDG PET) imaging. First, the PSP‐RS–related pattern, PSP‐P–related pattern, PSP‐PGF–related pattern (PGFRP), and PSP‐PI–related pattern (PIRP) were identified by scaled subprofile modeling/principal‐component analysis. Furthermore, we evaluated the similarity of these patterns to previously reported PSPRP and tested their ability to classify clinical phenotypes. Finally, we evaluated these patterns longitudinally for monitoring disease progression and predicting conversion of vPSP to PSP‐RS.

Results

All type‐specific patterns showed significant topographic similarity and association with PSPRP. The PGFRP exhibited more extensive involvement in the striatum than other type‐specific patterns. In general, both type‐specific patterns and PSPRP demonstrated similar performance in distinguishing PSP‐RS from vPSP. Pattern expressions increased at follow‐up and correlated with clinical progression. Higher baseline pattern expressions significantly predicted conversion from vPSP to PSP‐RS.

Conclusions

PSP phenotypes exhibit type‐specific metabolic covariance patterns that largely overlap with PSPRP but show phenotype‐relevant differences. These patterns hold promise for longitudinal monitoring of disease progression and prediction of vPSP conversion to PSP‐RS. © 2026 International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Supranuclear Palsy, ProgressiveParkinsonian DisordersHumansLongitudinal StudiesFemalePositron-Emission TomographyMaleDisease ProgressionAgedFluorodeoxyglucose F18Middle Aged

Stichwörter der Autor:innen

disease‐specific metabolic patternpositron emission tomographyprogressive supranuclear palsyvariant

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Nuclear Medicine & PET Center, National Clinical Research Center for Aging and Medicine, National Center for Neurological Disorders, Huashan Hospital, Fudan University, Shanghai, China.
  • Department of Neurology, National Research Center for Aging and Medicine, National Center for Neurological Disorders, State Key Laboratory of Medical Neurobiology, Huashan Hospital, Fudan University, Shanghai, China.

ORCID-Profile: Fangyang Jiao, Jiaying Lu, Fengtao Liu, Jian Wang, Chuantao Zuo

Förderung

  • National Natural Science Foundation of China
  • STI2030-Major Project of China
  • International Human Phenome Project: Deep Phenomics Study of Sleep Disorders
  • Postdoctoral Fund of The First Affiliated Hospital of Chongqing Medical University

Zitieren

APA

Jiao, F., Lin, H., Lu, J., Liu, F., Wang, J., Wu, J., Pang, H., Wang, J., Zuo, C., Wu, P., & Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI) (2026). Disease‐Specific Metabolic Patterns in Progressive Supranuclear Palsy with Richardson's Syndrome and Variants: A Longitudinal Study. Movement Disorders. https://doi.org/10.1002/mds.70369

Vancouver

Jiao F, Lin H, Lu J, Liu F, Wang J, Wu J, et al. Disease‐Specific Metabolic Patterns in Progressive Supranuclear Palsy with Richardson's Syndrome and Variants: A Longitudinal Study. Movement Disorders. 2026. doi:10.1002/mds.70369

BibTeX
@article{Jiao2026,
  author = {Jiao, Fangyang and Lin, Huamei and Lu, Jiaying and Liu, Fengtao and Wang, Jing and Wu, Jianjun and Pang, Hua and Wang, Jian and Zuo, Chuantao and Wu, Ping and Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI), Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI)},
  title = {Disease‐Specific Metabolic Patterns in Progressive Supranuclear Palsy with Richardson's Syndrome and Variants: A Longitudinal Study},
  journal = {Movement Disorders},
  year = {2026},
  doi = {10.1002/mds.70369}
}
Kostenlos starten →